Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosanne F Vogel

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Reviews in Cardiovascular Medicine|July 30, 2024
Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCIRosanne F Vogel, Ronak Delewi, Lina Badimon, et al.
Circulation|December 14, 2020
Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH TrialGeorgios J Vlachojannis, Jeroen M Wilschut, Rosanne F Vogel, et al.
American Heart Journal|April 10, 2020
COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trialGeorgios J Vlachojannis, Rosanne F Vogel, Jeroen M Wilschut, et al.
Journal of the American Heart Association|February 22, 2021
Clinical Course Long After Atrial Switch: A Novel Risk Score for Major Clinical EventsOdilia I Woudstra, Tjitske E Zandstra, Rosanne F Vogel, et al.
American Heart Journal|June 7, 2022
Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction-1-year follow-up results of the COMPARE CRUSH trialRosanne F Vogel, Ronak Delewi, Jeroen M Wilschut, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Prehospital crushed versus integral prasugrel loading dose in STEMI patients with a large myocardial areaJeroen M Wilschut, Rosanne F Vogel, Jacob J Elscot, et al.
Journal of Clinical Medicine|October 28, 2023
Direct Stenting versus Conventional Stenting in Patients with ST-Segment Elevation Myocardial Infarction-A COMPARE CRUSH Sub-StudyRosanne F Vogel, Ronak Delewi, Jeroen M Wilschut, et al.
JACC. Cardiovascular Interventions|June 25, 2021
Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial InfarctionRosanne F Vogel, Ronak Delewi, Dominick J Angiolillo, et al.
American Heart Journal|January 3, 2023
Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarctionRonak Delewi, Rosanne F Vogel, Jeroen M Wilschut, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Reviews in Cardiovascular Medicine|July 30, 2024
Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCIRosanne F Vogel, Ronak Delewi, Lina Badimon, et al.
Circulation|December 14, 2020
Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH TrialGeorgios J Vlachojannis, Jeroen M Wilschut, Rosanne F Vogel, et al.
American Heart Journal|April 10, 2020
COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trialGeorgios J Vlachojannis, Rosanne F Vogel, Jeroen M Wilschut, et al.
Journal of the American Heart Association|February 22, 2021
Clinical Course Long After Atrial Switch: A Novel Risk Score for Major Clinical EventsOdilia I Woudstra, Tjitske E Zandstra, Rosanne F Vogel, et al.
American Heart Journal|June 7, 2022
Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction-1-year follow-up results of the COMPARE CRUSH trialRosanne F Vogel, Ronak Delewi, Jeroen M Wilschut, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Prehospital crushed versus integral prasugrel loading dose in STEMI patients with a large myocardial areaJeroen M Wilschut, Rosanne F Vogel, Jacob J Elscot, et al.
Journal of Clinical Medicine|October 28, 2023
Direct Stenting versus Conventional Stenting in Patients with ST-Segment Elevation Myocardial Infarction-A COMPARE CRUSH Sub-StudyRosanne F Vogel, Ronak Delewi, Jeroen M Wilschut, et al.
JACC. Cardiovascular Interventions|June 25, 2021
Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial InfarctionRosanne F Vogel, Ronak Delewi, Dominick J Angiolillo, et al.
American Heart Journal|January 3, 2023
Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarctionRonak Delewi, Rosanne F Vogel, Jeroen M Wilschut, et al.
Pageof 1